Glutathione transporter as a target for brain-targeting drug delivery The first report using GSH as a brain targeting agent was from Wang et al
Figure 2 ME/CFS severity classifications The long-term outlook for ME/CFS patients varies significantly (11)
Formerly a researcher in thematics varying from cardiology to neurodegenerative diseases, she is now part of Long Long Life team and is involved in scientific writing and anti-aging research
About 3075% of women with PCOS are obese [55] and such patients are likely at more risk to suffer from severe consequences than PCOS, such as hyperandrogenism and metabolic syndrome, compared to patients with a normal BMI [1, 56]
To provide optimal protection against radical-mediated damage, both enzymatic and non-enzymatic antioxidants are strategically compartmentalized (e.g., organelles vs
10 This additional revenue is extracted entirely through one single follow-on patent that covers an inherent property already disclosed and protected in the original 208 compound patent
